Dr. Tourigny’s drug cocktails, which include drugs similar to protease inhibitors used to treat HIV infection, are intended to help stop progression of the disease and other positive outcomes, including preventing cirrhosis, reducing risk for liver cancer and reducing the need for liver transplantation.
Such drug therapies are available to patients at CarolinaEast Gastroenterology, and their use has brought about positive results, according to the report.
Related Articles on Gastroenterologists:
West Side GI Surgery Center Opens in Manhattan
Gastroenterologist Dr. Max Schneider Retires at 90
Gastroenterologist Dr. Imad Idriss Recognized by NM’s Memorial Medical Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
